BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26336985)

  • 21. Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma.
    Koh YW; Park C; Yoon DH; Suh C; Huh J
    Am J Surg Pathol; 2013 Aug; 37(8):1242-51. PubMed ID: 23851330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.
    Campos AH; Vassallo J; Soares FA
    PLoS One; 2013; 8(9):e74793. PubMed ID: 24086377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival.
    Venkataraman G; Song JY; Tzankov A; Dirnhofer S; Heinze G; Kohl M; Traverse-Glehen A; Eberle FC; Hanson JC; Raffeld MA; Pittaluga S; Jaffe ES
    Blood; 2013 Mar; 121(10):1795-804. PubMed ID: 23305738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S
    PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
    Gupta GK; Agrawal T; Pilichowska M
    BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
    Reichel J; Chadburn A; Rubinstein PG; Giulino-Roth L; Tam W; Liu Y; Gaiolla R; Eng K; Brody J; Inghirami G; Carlo-Stella C; Santoro A; Rahal D; Totonchy J; Elemento O; Cesarman E; Roshal M
    Blood; 2015 Feb; 125(7):1061-72. PubMed ID: 25488972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
    Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
    Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
    Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
    Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
    Steidl C; Lee T; Shah SP; Farinha P; Han G; Nayar T; Delaney A; Jones SJ; Iqbal J; Weisenburger DD; Bast MA; Rosenwald A; Muller-Hermelink HK; Rimsza LM; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Jaffe ES; Lenz G; Connors JM; Staudt LM; Chan WC; Gascoyne RD
    N Engl J Med; 2010 Mar; 362(10):875-85. PubMed ID: 20220182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
    Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
    APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
    Koh YW; Yoon DH; Suh C; Cha HJ; Huh J
    Int J Exp Pathol; 2015 Aug; 96(4):232-9. PubMed ID: 25916750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
    Sasi W; Jiang WG; Sharma A; Mokbel K
    BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
    Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
    Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.
    Bohle V; Döring C; Hansmann ML; Küppers R
    Leukemia; 2013 Mar; 27(3):671-9. PubMed ID: 23174882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
    Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
    Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
    Gomez F; Fisk B; McMichael JF; Mosior M; Foltz JA; Skidmore ZL; Duncavage EJ; Miller CA; Abel H; Li YS; Russler-Germain DA; Krysiak K; Watkins MP; Ramirez CA; Schmidt A; Martins Rodrigues F; Trani L; Khanna A; Wagner JA; Fulton RS; Fronick CC; O'Laughlin MD; Schappe T; Cashen AF; Mehta-Shah N; Kahl BS; Walker J; Bartlett NL; Griffith M; Fehniger TA; Griffith OL
    Cancer Res Commun; 2023 Nov; 3(11):2312-2330. PubMed ID: 37910143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
    Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
    Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.